COLLECT AND PROCESS PERSONAL INFORMATION CONSENT
Personal information (such as your first and last name and email address) collected from you to receive EpiPen^® Newsletters will be used by Pfizer Canada ULC ("Pfizer Canada") to email you communications on important EpiPen^® updates, product information, as well as helpful lifestyle tips, health, wellness, and Pfizer-related programs from Pfizer Canada.
Your personal information may also be disclosed and/or transferred to a third party in the event of a proposed or actual purchase, sale (including a liquidation, realization, foreclosure or repossession), lease, merger, amalgamation or any other type of acquisition, disposal, transfer, conveyance or financing of all or any portion of Pfizer Canada or of any of the business or assets or shares of Pfizer Canada or a division thereof. Please note that sharing of personal information with service providers or disclosures to third parties may involve the storage or processing of personal information outside of Canada (including in the United States) where local privacy laws may require the disclosure of personal information to governmental authorities under circumstances that are different than those that apply in Canada.
By submitting your personal information, you consent to the manner of collection, use and disclosure of personal information as described above. If you later change your mind about such collection, use and disclosure for any reason, you may withdraw your consent, by contacting Pfizer Canada as set forth below. You have a right to access and correct your information, where required. If you have any inquiry concerning your personal information, please contact Pfizer Canada ULC at P.O. Box 800, Pointe-Claire – Dorval, Quebec H9R 4V2 or by phone at 1-888-637-5464. Further information about Pfizer Canada's privacy practices is available here.